A recently published study by Fact.MR suggests that the global gene therapy market is projected to grow at a compound annual growth rate (CAGR) of 18.5% from 2022 to 2032, reaching a valuation of US$10.1 billion. By 2022, the market is expected to reach a value of US$1.85 billion. The increasing pursuit of breakthroughs in medical treatments has driven the demand for gene therapy across various grades.
